Publications by authors named "L M Nijm"
Purpose: To study the association between tear film hyperosmolarity and ocular light scatter in a cataract surgery population.
Patients And Methods: Contiguous, 20-second objective scatter index (OSI) scans were recorded in hyperosmolar (≥320 mOsm/L) and normal subjects (<308 mOsm/L) with cataract nuclear opacity ≥3. OSI was measured at screening, baseline and 90 days following surgery.
Purpose: To evaluate the effectiveness and safety of a crosslinked hyaluronate (HA) canalicular filler (Lacrifill Canalicular Gel) compared with a commercially available hydrogel canalicular plug (Form Fit).
Setting: 5 sites in the United States.
Design: Prospective, multicenter, controlled, double-masked, randomized 2:1 (filler:plug).
Purpose: To evaluate both the early experience of real-world patients treated with dexamethasone ophthalmic insert (0.4 mg; DEXTENZA), hereafter referred to as DEX, after cataract surgery as well as staff/practice integration of DEX relative to eyedrops.
Patients And Methods: This was a cross-sectional survey study of 23 cataract practices in the United States.
Article Synopsis
- This study evaluated the long-term effects of lotilaner ophthalmic solution, 0.25%, for treating Demodex blepharitis, involving 239 patients who completed a prior study and returned for follow-ups at 180 and 365 days post-treatment.
- Results showed a significantly higher number of patients in the lotilaner group with fewer collarettes (indicators of infestation) compared to the control group, with improvement continuing even after treatment ended, and only mild adverse events reported.
- The conclusions suggest that the treatment remains effective over a year, with no significant long-term safety issues, indicating that the benefits of lotilaner may extend beyond the initial treatment period.
Newly approved treatments for patients with geographic atrophy are changing the treatment paradigm, highlighting the need for eye care providers (ECPs) to have a set of recommendations on how to best manage GA patients. Here, we outline how to identify various stages of age-related macular degeneration including geographic atrophy (GA) by examining optimal management scenarios implicating various ECPs and reviewing treatment considerations for patients with GA. Early identification of GA will lead to optimal patient outcomes, while a standardized management scenario will reduce clinical burden among ECPs treating patients with GA.
View Article and Find Full Text PDF